This paper describes the discovery of non-peptidic, potent, and selective hydroxy ethylamine (HEA) inhibitors of BACE-1 by replacement of the prime side of a lead di-amide
2. Inhibitors with nanosmolar potency and high selectivity were identified. Depending on the nature of the
and
substituents, two different binding modes were observed in X-ray co-crystal structures.